Antipathogenic activity of probiotics against Salmonella Typhimurium and Clostridium difficile in anaerobic batch culture systems: Is it due to synergies in probiotic mixtures or the specificity of single strains?

Anaerobe

Volumn 24, Issue , 2013, Pages 60-65

  Tejero Sariñena, Sandra ^a   Barlow, Janine ^b   Costabile, Adele ^a   Gibson, Glenn R ^a   Rowland, Ian ^a  

^a UNIVERSITY OF READING   (United Kingdom)

^b Lopen Head   (United Kingdom)

Author keywords

Antibacterial activity; Enteric pathogens; Organic acids; PH controlled anaerobic batch cultures; Probiotics

Indexed keywords

ACETIC ACID; FORMIC ACID; LACTIC ACID; PROBIOTIC AGENT;

ANTIMICROBIAL ACTIVITY; ANTIPATHOGENIC ACTIVITY; ARTICLE; BACILLUS; BACTERIAL COUNT; BACTERIAL STRAIN; BACTERIAL SURVIVAL; BACTERIUM CULTURE; BIFIDOBACTERIUM; BIFIDOBACTERIUM BREVE; CLOSTRIDIUM DIFFICILE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FECES; FERMENTATION; IN VITRO STUDY; LACTOBACILLUS; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS CASEI; LACTOCOCCUS; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SALMONELLA TYPHIMURIUM; STREPTOCOCCUS;

ANTIBACTERIAL ACTIVITY; ENTERIC PATHOGENS; ORGANIC ACIDS; PH-CONTROLLED ANAEROBIC BATCH CULTURES; PROBIOTICS;

ACETATES; ANAEROBIOSIS; ANTIBIOSIS; BATCH CELL CULTURE TECHNIQUES; CLOSTRIDIUM DIFFICILE; CULTURE MEDIA; FORMATES; HUMANS; HYDROGEN-ION CONCENTRATION; LACTATES; LACTOBACILLALES; LACTOBACILLUS CASEI; PROBIOTICS; SALMONELLA TYPHIMURIUM;

EID: 84885938503     PISSN: 10759964     EISSN: 10958274     Source Type: Journal    
DOI: 10.1016/j.anaerobe.2013.09.011     Document Type: Article

References (33)

1. Manichanh C., Rigottier-Gois L., Bonnaud E., Gloux K., Pelletier E., Frangeul L., et al. Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut 2006, 55:205-211.
2. Codling C., O'Mahony L., Shanahan F., Quigley E.M., Marchesi J.R. Amolecular analysis of fecal and mucosal bacterial communities in irritable bowel syndrome. Dig Dis Sci 2010, 55:392-397.
3. Frank D.N., Robertson C.E., Hamm C.M., Kpadeh Z., Zhang T., Chen H., et al. Disease phenotype and genotype are associated with shifts in intestinal-associated microbiota in inflammatory bowel diseases. Inflamm Bowel Dis 2011, 17:179-184.
4. Maccaferri S., Candela M., Turroni S., Centanni M., Severgnini M., Consolandi C., et al. IBS-associated phylogenetic unbalances of the intestinal microbiota are not reverted by probiotic supplementation. Gut Microbe 2012, 3:406-413.
5. Mueller S., Saunier K., Hanisch C., Norin E., Alm L., Midtvedt T., et al. Differences in fecal microbiota in different European study populations in relation to age, gender, and country: a cross-sectional study. Appl Environ Microbiol 2006, 72:1027-1033.
6. Biagi E., Nylund L., Candela M., Ostan R., Bucci L., Pini E., et al. Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians. PLoS One 2010, 5:e10667.
7. Claesson M.J., Jeffery I.B., Conde S., Power S.E., O'Connor E.M., Cusack S., et al. Gut microbiota composition correlates with diet and health in the elderly. Nature 2012, 488:178-184.
8. Biagi E., Candela M., Fairweather-Tait S., Franceschi C., Brigidi P. Aging of the human metaorganism: the microbial counterpart. Age (Dordr) 2012, 34:247-267.
9. FAO/WHO Report of a joint FAO/WHO expert consultation on guidelines for the evaluation of probiotics in food 2002, World Health Organization and Food and Agriculture Organization of the United Nations, London Ontario, Canada.=
10. WHO, 2005. http://www.who.int/mediacentre/factsheets/fs139/en.
11. Coburn B., Grassl G.A., Finlay B.B. Salmonella, the host and disease: a brief review. Immunol Cell Biol 2007, 85:112-118.
12. Sekirov I., Tam N.M., Jogova M., Robertson M.L., Li Y., Lupp C., et al. Antibiotic-induced perturbations of the intestinal microbiota alter host susceptibility to enteric infection. Infect Immun 2008, 76:4726-4736.
13. Ferreira R.B.R., Gill N., Willing B.P., Antunes L.C.M., Russell S.L., Croxen M.A., et al. The intestinal microbiota plays a role in Salmonella-induced colitis independent of pathogen colonization. PLoS One 2011, 6:e20338.
14. Kelly C.P., Pothoulakis C., Lamont J.T. Clostridium difficile colitis. New Engl J Med 1994, 330:257-262.
15. Plummer S., Weaver M.A., Harris J.C., Dee P., Hunter J. Clostridium difficile pilot study: effects of probiotic supplementation on the incidence of C.difficile diarrhea. Int Microbiol 2004, 7:59-62.
16. Kotowska M., Albrecht P., Szajewska H. Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea in children: a randomized double-blind placebo-controlled trial. Aliment Pharm Therap 2005, 21:583-590.
17. Hickson M., D'Souza A.L., Muthu N., Rogers T.R., Want S., Rajkumar C., et al. Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial. Br Med J 2007, 335:80-83.
18. Ruszczynski M., Radzikowski A., Szajewska H. Clinical trial: effectiveness of Lactobacillus rhamnosus (strains E/N, Oxy and Pen) in the prevention of antibiotic-associated diarrhoea in children. Aliment Pharm Therap 2008, 28:154-161.
19. Hickson M. Probiotics in the prevention of antibiotic-associated diarrhoea and Clostridium difficile infection. Therap Adv Gastroenterol 2011, 4:185-197.
20. Chapman C.M.C., Gibson G.R., Rowland I. Invitro evaluation of single- and multi-strain probiotics: inter-species inhibition between probiotic strains, and inhibition of pathogens. Anaerobe 2012, 18:405-413.
21. Ricke S.C. Perspectives on the use of organic acids and short chain fatty acids as antimicrobials. Poultry Sci 2003, 82:632-639.
22. Macfarlane G.T., Macfarlane S., Gibson G.R. Validation of a three-stage compound continuous culture system for investigating the effect of retention time on the ecology and metabolism of bacteria in the human colon. Microbial Ecol 1998, 35:180-187.
23. Gomez E., Tuohy K.M., Gibson G.R., Klinder A., Costabile A. Invitro evaluation of the fermentation properties and potential prebiotic activity of Agave fructans. JAppl Microbiol 2010, 108:2114-2121.
24. Langendijk P.S., Schut F., Jansen G.J., Raangs G.C., Kamphuis G.R., Wilkinson M.H.F., et al. Quantitative fluorescence in-situ hybridization of Bifidobacterium spp with genus-specific 16S ribosomal-RNA-targeted probes and its application in fecal samples. Appl Environ Microbiol 1995, 61:3069-3075.
25. Fallani M., Rigottier-Gois L., Aguilera M., Bridonneau C., Collignon A., Edwards C.A., et al. Clostridium difficile and Clostridium perfringens species detected in infant faecal microbiota using 16S rRNA targeted probes. JMicrobiol Meth 2006, 67:150-161.
26. Daims H., Bruhl A., Amann R., Schleifer K.H., Wagner M. The domain-specific probe EUB338 is insufficient for the detection of all bacteria: development and evaluation of a more comprehensive probe set. Syst Appl Microbiol 1999, 22:434-444.
27. Harmsen H.J.M., Elfferich P., Schut F., Welling G.W. A16S rRNA-targeted probe for detection of lactobacilli and enterococci in faecal samples by fluorescent in situ hybridization. Microb Ecol Health Dis 1999, 11:3-12.
28. Nordentoft S., Christensen H., Wegener H.C. Evaluation of a fluorescence-labelled oligonucleotide tide probe targeting 23S rRNA for in situ detection of Salmonella serovars in paraffin-embedded tissue sections and their rapid identification in bacterial smears. JClin Microbiol 1997, 35:2642-2648.
29. Buddington R. Using probiotics and prebiotics to manage the gastrointestinal tract ecosystem. Prebiotics and probiotics science and technology 2009, 1-31. Springer, New York. D. Charalampopoulos, B. Rastall (Eds.).
30. Macfarlane G.T., Gibson G.R., Cummings J.H. Comparison of fermentation reactions in different regions of the human colon. JAppl Bacteriol 1992, 72:57-64.
31. Duncan S.H., Louis P., Flint H.J. Lactate-utilizing bacteria, isolated from human feces, that produce butyrate as a major fermentation product. Appl Environ Microbiol 2004, 70:5810-5817.
32. Bourriaud C., Robins R.J., Martin L., Kozlowski F., Tenailleau E., Cherbut C., et al. Lactate is mainly fermented to butyrate by human intestinal microfloras but inter-individual variation is evident. JAppl Microbiol 2005, 99:201-212.
33. Macfarlane S., Macfarlane G.T. Regulation of short-chain fatty acid production. Proc Nutr Soc 2003, 62:67-72.